esketamine  - Drug Details
📊 Estimates esketamine  Dialyzability By Different_Modalities

esketamine 

Complete Drug Information

Drug Name
esketamine 
Trade Names
Spravato, Ketanest, Spravado
Pregnancy Category
AU: B3
Bioavailability
Intranasal: 30–50%
Routes of Administration
Intranasal, intravenous
Elimination
5 hours
Formula
C13H16ClNO
Molar Mass
237.73
Drug Class
NMDA receptor antagonist; Antidepressant; General anesthetic; Dissociative hallucinogen; Analgesic
Volume of Distribution
C13H16ClNO

🤰 Pregnancy Category Information

Category: AU: B3

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies have shown evidence of an increased occurrence of fetal damage, the significance of which is considered uncertain in humans.